Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin, UFT, and Radiotherapy in Rectal Cancer
NCT00403624Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jul 2001
- Primary completion
- Nov 2005
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of oxaliplatin in rectal cancer, sponsored by Sanofi. Started Jul 2001; status: completed.
02
Drugs
oxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00403624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403624.